A61K 39/0007
Nervous system antigens
Official title: {Nervous system antigens; Prions}
A61K39/0007 (Nervous system antigens) appears on 260 US grants and 535 published applications in this corpus.
Search patents in A61K- Granted patents
- 260
- Published applications
- 535
- Assignees
- 213
- Inventors
- 698
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 1 |
| 2002 | 0 | 7 |
| 2003 | 2 | 16 |
| 2004 | 14 | 28 |
| 2005 | 14 | 31 |
| 2006 | 8 | 15 |
| 2007 | 3 | 19 |
| 2008 | 4 | 26 |
| 2009 | 9 | 30 |
| 2010 | 6 | 24 |
| 2011 | 17 | 30 |
| 2012 | 10 | 18 |
| 2013 | 9 | 23 |
| 2014 | 19 | 25 |
| 2015 | 20 | 25 |
| 2016 | 19 | 25 |
| 2017 | 16 | 24 |
| 2018 | 12 | 20 |
| 2019 | 10 | 15 |
| 2020 | 15 | 17 |
| 2021 | 9 | 21 |
| 2022 | 6 | 20 |
| 2023 | 8 | 26 |
| 2024 | 13 | 16 |
| 2025 | 8 | 21 |
| 2026 | 7 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Multiepitope vaccine for the treatment of ALZHEIMER'S disease23 Jun 2026US 12,661,392 B2Othair Prothena Limited
- Anti-Nogo-A antibodies and methods of making and using thereof23 Jun 2026US 12,662,528 B2NovaGo Therapeutics AG
- Binding molecule binding to traumatic brain injury-associated tau and methods of use thereof23 Jun 2026US 12,662,678 B2Arizona Board of Regents on behalf of Arizona State University
- Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy16 Jun 2026US 12,653,872 B2AC Immune SA
- Monoclonal antibodies against pathological tau, and methods of detection thereof12 May 2026US 12,624,095 B2The Trustees of the University of Pennsylvania
- Vaccination against the amyloid-beta 40 peptide17 Sep 2026US 2026/0273032 A1Araclon Biotech, S.L.
- Modified virus-like particles of cmv10 Sep 2026US 2026/0263612 A1Saiba GmbH
- Tau and amyloid beta peptide immunogen compositions and related methods6 Aug 2026US 2026/0224676 A1Vaxxinity, Inc.
- Tau peptide immunogen constructs30 Jul 2026US 2026/0216305 A1Vaxxinity, Inc.
- Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease2 Jul 2026US 2026/0184772 A1Axon Neuroscience SE
Most cited
By later US patents
- Prevention and treatment of amyloidogenic disease160US 6,743,427 B1Neuralab Limited · 2004
- N-Terminal amyloid-β antibodies116US 6,787,637 B1Neuralab Limited · 2004
- Humanized and chimeric N-terminal amyloid beta-antibodies109US 6,750,324 B1Neuralab Limited · 2004
- Passive immunization of Alzheimer's disease99US 6,913,745 B1Neuralab Limited · 2005
- Materials and methods for treatment of plaquing diseases96US 5,851,996 AMilkhaus Laboratory, Inc. · 1998